Hung-Yuan Huang

Title: Innovations of Hung-Yuan Huang in Tumor Imaging and Therapy

Introduction

Hung-Yuan Huang is a notable inventor based in Kaohsiung, Taiwan. He has made significant contributions to the field of pharmaceutical compositions, particularly in tumor imaging and therapy. His innovative work focuses on developing compounds that enhance the specificity of treatments for tumor cells.

Latest Patents

Hung-Yuan Huang holds a patent for a compound and pharmaceutical composition designed for tumor imaging and therapy. The patent describes a compound represented by formula (I), where Rand Reach independently represents hydrogen, O—R, or S—R. At least one of Rand Ris O—R or S—R, and Rand Rare independently a Cto Calkyl group. This Cto Calkyl group can be non-substituted or substituted with various functional groups, including —OH, —NH, halogen, ester, ether, and carboxylic acid, with M being a metal or a metal-containing compound. The compound has demonstrated higher specificity to tumor cells, making it suitable for carrying anti-cancer drugs and/or nuclear imaging agents.

Career Highlights

Hung-Yuan Huang is associated with Seecure Taiwan Co., Ltd., where he continues to advance his research and development efforts. His work has positioned him as a key figure in the pharmaceutical industry, particularly in the area of cancer treatment.

Collaborations

He collaborates with esteemed colleagues such as Wei-Chung Chang and Kun-Hsin Lee, contributing to a dynamic research environment that fosters innovation and discovery.

Conclusion

Hung-Yuan Huang's contributions to tumor imaging and therapy through his patented innovations highlight the importance of targeted treatments in cancer care. His work continues to pave the way for advancements in pharmaceutical compositions that can significantly impact patient outcomes.